Sam-A Pharm. Co., Ltd (KOSDAQ:009300)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,970
+280 (2.05%)
At close: Aug 24, 2026

Sam-A Pharm. Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
19,6396,5809,5519,0199,1767,984
Short-Term Investments
21,60239,60248,63861,63868,63845,638
Trading Asset Securities
56,56551,46018,4748,4473,197-
Cash & Short-Term Investments
97,80697,64276,66479,10481,01153,623
Cash Growth
10.75%27.36%-3.08%-2.35%51.08%-16.68%
Accounts Receivable
17,63319,46819,06022,59621,46618,039
Other Receivables
2,0592,0812,7943,0792,0251,293
Receivables
19,69221,54821,85425,67523,49119,332
Inventory
14,73016,46814,28313,01312,2449,341
Prepaid Expenses
-207.19135.22160.7671.1444.88
Other Current Assets
253.752.96153.4638.3740.2713.96
Total Current Assets
132,481135,869113,089117,992116,85682,355
Property, Plant & Equipment
37,93639,17342,75040,51137,16440,188
Long-Term Investments
55,05650,14171,93961,36242,95760,434
Other Intangible Assets
5,4204,6414,1894,2954,3945,537
Long-Term Deferred Tax Assets
928.55420.53519.3980.271,041-
Other Long-Term Assets
6,9886,9386,8197,067786.49657.77
Total Assets
249,777247,045248,734231,308203,198189,172

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
4,0744,1785,8305,0027,0403,772
Accrued Expenses
-1,360907.142,2291,74515.74
Current Portion of Long-Term Debt
-2,2784,5561,667-2,407
Current Portion of Leases
1,7891,8201,8351,8581,7251,709
Current Income Taxes Payable
295.75233.333,7213,5424,3861,580
Other Current Liabilities
6,9484,0223,6596,8476,6625,111
Total Current Liabilities
13,10713,89120,50821,14521,55814,594
Long-Term Debt
2,621-2,2782,500--
Long-Term Leases
2,0792,8444,2215,645451,509
Pension & Post-Retirement Benefits
88.2343.4282.87---
Long-Term Deferred Tax Liabilities
--18.2412.0512.05175.08
Other Long-Term Liabilities
2,2352,1551,6501,536964.81868.76
Total Liabilities
20,13018,93428,75830,83822,58017,147

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
6,3706,3706,3706,3706,3706,370
Additional Paid-In Capital
14,41314,41314,41314,41314,41314,413
Retained Earnings
205,561204,168196,482179,204160,354149,836
Treasury Stock
-1,513-1,513-1,513-1,513-1,513-1,513
Comprehensive Income & Other
4,8164,6734,2231,996992.922,917
Shareholders' Equity
229,647228,111219,976200,470180,618172,024
Total Liabilities & Equity
249,777247,045248,734231,308203,198189,172

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
6,4896,94212,89011,6691,7705,625
Net Cash (Debt)
91,31790,70063,77467,43579,24147,998
Net Cash Growth
16.46%42.22%-5.43%-14.90%65.09%-16.01%
Net Cash Per Share
14957.8214860.7010450.1211048.8512983.197864.24
Filing Date Shares Outstanding
6.16.16.16.16.16.1
Total Common Shares Outstanding
6.16.16.16.16.16.1
Working Capital
119,374121,97792,58196,84895,29867,761
Book Value Per Share
37628.3337374.7336041.8632845.9729593.2828185.26
Tangible Book Value
224,227223,470215,787196,175176,224166,488
Tangible Book Value Per Share
36740.2536614.3935355.5732142.1928873.3227278.10
Land
-4,3464,3464,3469,3439,343
Buildings
-30,47230,47230,47230,44530,445
Machinery
-30,70329,43524,79123,85624,141
Construction In Progress
-389.961,8361,17445.734.03